Doctor profile · Federal record
Dr. FNU DEEPIKA, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · WATERLOO, IA
- NPI 1386166171
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2710 SAINT FRANCIS DR STE 300
WATERLOO, IA 507025620
(319) 272-5000
fax (319) 272-5690
Credentials & registration
- NPI registered
- July 2017 — 9 yrs on file
- Profile last updated
- June 29, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Iowa #MD-49073 · Texas #BP10060523
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386166171. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
436
Distinct HCPCS
5
Medicare allowed
$44,972
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 139 | 70 | $134 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 91 | 91 | $168 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 90 | 41 | $32 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 77 | 51 | $91 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 39 | 32 | $29 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 87. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$666
Transactions
33
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 8 | $157.40 | |
| Lilly USA, LLC | 5 | $103.63 | |
| Amgen Inc. | 4 | $69.32 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64.60 | |
| Radius Health, Inc. | 2 | $57.32 | |
| Abbott Laboratories | 2 | $47.73 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38.59 | |
| Kyowa Kirin, Inc. | 1 | $21.90 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.89 | |
| Alexion Pharmaceuticals, Inc. | 1 | $21.37 | |
| Medtronic, Inc. | 1 | $18.58 | |
| Almatica Pharma LLC | 1 | $17.81 | |
| Dexcom, Inc. | 1 | $13.26 | |
| RECORDATI_RARE_DISEASES_INC. | 1 | $13.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
706
Patients
114
Total drug cost
$538,604
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mounjaro (Tirzepatide) | Brand | 141 | 20 | $172,003 |
| Ozempic (Semaglutide) | Brand | 126 | 30 | $145,928 |
| Levothyroxine Sodium | Generic | 61 | 13 | $445 |
| Jardiance (Empagliflozin) | Brand | 48 | 14 | $75,885 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 44 | 12 | $26,581 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 42 | 14 | $23,294 |
| Metformin Hcl | Generic | 40 | 11 | $413 |
| Trulicity (Dulaglutide) | Brand | 40 | 0 | $53,676 |
| Rosuvastatin Calcium | Generic | 34 | 0 | $449 |
| Atorvastatin Calcium | Generic | 24 | 0 | $230 |